Patent Assignment
Reel/Frame 063842/0495
Assignment of Assignor's Interest
Recorded: 2023-06-02
Pages: 46
Assignor
SHIRE HUMAN GENETIC THERAPIES, INC.
Executed: 2022-07-11
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, JAPAN
Covered Property
(1)
Compositions Comprising Iduronate-2-Sulfatase
Application:
18/052,442 →
Publication:
US 2024/0043817
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.